A total of 7997 CHF‐T2DM patients were included, with 6112 from MIMIC (2241 received insulin therapy and 3871 not), and 1885 from TJHFIT (911 received insulin therapy and 974 not). The gene discussed is INS; the disease is type 2 diabetes mellitus.